{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T23:52:50Z","timestamp":1793922770646,"version":"4.8.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,7,15]],"date-time":"2021-07-15T00:00:00Z","timestamp":1626307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,7,15]],"date-time":"2021-07-15T00:00:00Z","timestamp":1626307200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Oral Health"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Oral lichen planus is an autoimmune disease in which topical steroids are the first line of treatment. The adverse effects of systemic corticosteroids prescribed for resistant oral lichen planus cases advocate alternative modalities. Lycopene is an antioxidant with a wide range of beneficial properties. This trial aimed to evaluate the effect of pure lycopene as compared to systemic corticosteroids (Prednisolone) on the symptoms, signs and oxidative stress in patients with erosive oral lichen planus recalcitrant to topical steroids.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Twenty patients were randomly divided into the test (lycopene) and control (corticosteroids) groups. Numeric rating scale and Escudier et al. (Br J Dermatol 4:765\u2013770, 2007. <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"doi\" xlink:href=\"https:\/\/doi.org\/10.1111\/j.1365-2133.2007.08106.x\">10.1111\/j.1365-2133.2007.08106.x<\/jats:ext-link>) lesion scores were assessed at baseline and weeks 4 and 8 from baseline. Serum levels of 8-isoprostane were measured in all patients at baseline and at the end of treatment (week 8).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>There was a significant reduction in signs and symptoms after the end of treatment in each group. However, no significant difference was found between the lycopene and the corticosteroids group. Moreover, a significant reduction in 8-isoprostane levels was observed in the lycopene group from baseline and as compared to the control group.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Based on the study results, lycopene is a safe and effective therapeutic modality for resistant oral lichen planus. 8-isoprostane is a biomarker of lipid peroxidation that can be reduced by lycopene.<\/jats:p>\n                <jats:p><jats:italic>Trial registration ID<\/jats:italic>: PACTR202003484099670. 'Retrospectively registered on 11\/3\/2020'.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12903-021-01711-z","type":"journal-article","created":{"date-parts":[[2021,7,15]],"date-time":"2021-07-15T09:03:48Z","timestamp":1626339828000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Serum 8-isoprostane levels in patients with resistant oral lichen planus before and after treatment with lycopene: a randomized clinical trial"],"prefix":"10.1186","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2024-526X","authenticated-orcid":false,"given":"Aliaa Abdelmoniem Bedeir","family":"Eita","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azza Mohamed","family":"Zaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabah Abdelhady","family":"Mahmoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,7,15]]},"reference":[{"key":"1711_CR1","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1590\/s0365-05962010000500010","volume":"85","author":"AM Canto","year":"2010","unstructured":"Canto AM, M\u00fcller H, Freitas RR, Santos PS. Oral lichen planus (OLP): clinical and complementary diagnosis. An Bras Dermatol. 2010;85:669\u201375. https:\/\/doi.org\/10.1590\/s0365-05962010000500010.","journal-title":"An Bras Dermatol"},{"key":"1711_CR2","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1111\/j.1525-1470.2009.01072.x","volume":"27","author":"KE Walton","year":"2020","unstructured":"Walton KE, Bowers EV, Drolet BA, Holland KE. Childhood lichen planus: demographics of a U.S. population. Pediatr Dermatol. 2020;27:34\u20138. https:\/\/doi.org\/10.1111\/j.1525-1470.2009.01072.x.","journal-title":"Pediatr Dermatol"},{"key":"1711_CR3","doi-asserted-by":"publisher","first-page":"213","DOI":"10.5051\/jpis.2018.48.4.213","volume":"48","author":"SY Park","year":"2018","unstructured":"Park SY, Lee HJ, Kim SH, Kim SB, Choi YH, Kim YK, et al. Factors affecting treatment outcomes in patients with oral lichen planus lesions: a retrospective study of 113. J Periodontal Implant Sci. 2018;48:213\u201323. https:\/\/doi.org\/10.5051\/jpis.2018.48.4.213.","journal-title":"J Periodontal Implant Sci."},{"key":"1711_CR4","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001168.pub2","author":"K Thongprasom","year":"2011","unstructured":"Thongprasom K, Carrozzo M, Furness S, Lodi G. Interventions for treating oral lichen planus. Cochrane Database Syst Rev. 2011. https:\/\/doi.org\/10.1002\/14651858.CD001168.pub2.","journal-title":"Cochrane Database Syst Rev"},{"key":"1711_CR5","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1111\/1348-0421.12232","volume":"59","author":"K Wang","year":"2015","unstructured":"Wang K, Miao T, Lu W, He J, Cui B, Li J, et al. Analysis of oral microbial community and Th17-associated cytokines in saliva of patients with oral lichen planus. Microbiol Immunol. 2015;59:105\u201313. https:\/\/doi.org\/10.1111\/1348-0421.12232.","journal-title":"Microbiol Immunol"},{"key":"1711_CR6","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1046\/j.1468-3083.2003.00751.x","volume":"17","author":"S Briganti","year":"2003","unstructured":"Briganti S, Picardo M. Antioxidant activity, lipid peroxidation and skin diseases. What\u2019s new. J Eur Acad Dermatol Venereol. 2003;17:663\u20139. https:\/\/doi.org\/10.1046\/j.1468-3083.2003.00751.x.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"1711_CR7","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.20959\/wjpps20175-9144","volume":"6","author":"RP Kushwaha","year":"2017","unstructured":"Kushwaha RP, Rauniar GP, Rimal J. Comparative study of the efficacy of lycopene versus prednisolone in the management of oral lichen planus\u2014a randomized, double blind clinical trial. World J Pharm Pharm Sci. 2017;6:1103\u201315. https:\/\/doi.org\/10.20959\/wjpps20175-9144.","journal-title":"World J Pharm Pharm Sci."},{"key":"1711_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15761\/CRT.1000163","volume":"3","author":"A Alvarado","year":"2016","unstructured":"Alvarado A, Arce I. Antioxidants in respiratory diseases: basic science research and therapeutic alternatives. Clin Res Trials. 2016;3:1\u201311. https:\/\/doi.org\/10.15761\/CRT.1000163.","journal-title":"Clin Res Trials."},{"key":"1711_CR9","doi-asserted-by":"publisher","first-page":"757","DOI":"10.2147\/CIA.S158513","volume":"13","author":"I Liguori","year":"2018","unstructured":"Liguori I, Russo G, Curcio F, Bulli G, Aran L, Della-Morte D, et al. Oxidative stress, aging, and diseases. Clin Interv Aging. 2018;13:757\u201372. https:\/\/doi.org\/10.2147\/CIA.S158513.","journal-title":"Clin Interv Aging"},{"key":"1711_CR10","doi-asserted-by":"publisher","first-page":"387","DOI":"10.4103\/jomfp.JOMFP_19_17","volume":"21","author":"VR Rekha","year":"2017","unstructured":"Rekha VR, Sunil S, Rathy R. Evaluation of oxidative stress markers in oral lichen planus. J Oral Maxillofac Pathol. 2017;21:387\u201393. https:\/\/doi.org\/10.4103\/jomfp.JOMFP_19_17.","journal-title":"J Oral Maxillofac Pathol."},{"key":"1711_CR11","first-page":"21","volume":"17","author":"M Amirchaghmaghi","year":"2016","unstructured":"Amirchaghmaghi M, Hashemy SI, Alirezaei B, Keyhani FJ, Kargozar S, Vasigh S, et al. Evaluation of plasma isoprostane in patients with oral lichen planus. J Dent (Shiraz). 2016;17:21\u20135.","journal-title":"J Dent (Shiraz)"},{"key":"1711_CR12","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1016\/j.redox.2017.03.024","volume":"12","author":"TJ van\u2019t Erve","year":"2017","unstructured":"van\u2019t Erve TJ, Kadiiska MB, London SJ, Mason RP. Classifying oxidative stress by F2-isoprostane levels across human diseases: a meta-analysis. Redox Biol. 2017;12:582\u201399. https:\/\/doi.org\/10.1016\/j.redox.2017.03.024.","journal-title":"Redox Biol"},{"key":"1711_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.tripleo.2006.11.001","volume":"103 Suppl 25","author":"I Al-Hashimi","year":"2007","unstructured":"Al-Hashimi I, Schifter M, Lockhart PB, Wray D, Brennan M, Migliorati CA, et al. Oral lichen planus and oral lichenoid lesions: diagnostic and therapeutic considerations. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007;103 Suppl 25:1\u201312. https:\/\/doi.org\/10.1016\/j.tripleo.2006.11.001.","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"1711_CR14","doi-asserted-by":"publisher","first-page":"655","DOI":"10.4187\/respcare.06314","volume":"63","author":"DM Williams","year":"2018","unstructured":"Williams DM. Clinical pharmacology of corticosteroids. Respir Care. 2018;63:655\u201370. https:\/\/doi.org\/10.4187\/respcare.06314.","journal-title":"Respir Care"},{"key":"1711_CR15","doi-asserted-by":"crossref","unstructured":"Dasgupta A, Klein K. Herbal and other dietary supplements that are antioxidants. In: Dasgupta A, Klein K, editors. Antioxidants in food, vitamins and supplements, 1st edn. Amsterdam, Boston: Elsevier; 2014. p. 295\u2013315","DOI":"10.1016\/B978-0-12-405872-9.00016-1"},{"key":"1711_CR16","doi-asserted-by":"publisher","first-page":"70","DOI":"10.4103\/2008-7802.162311","volume":"6","author":"S Gupta","year":"2015","unstructured":"Gupta S, Jawanda MK, Arora V, Mehta N, Yadav V. Role of lycopene in preventing oral diseases as a nonsurgical aid of treatment. Int J Prev Med. 2015;6:70. https:\/\/doi.org\/10.4103\/2008-7802.162311.","journal-title":"Int J Prev Med"},{"key":"1711_CR17","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.ijsu.2011.10.001","volume":"10","author":"D Moher","year":"2012","unstructured":"Moher D, Hopewell S, Schulz KF, Montori V, G\u00f8tzsche PC, Devereaux PJ, et al. CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. Int J Surg. 2012;10:28\u201355.","journal-title":"Int J Surg"},{"key":"1711_CR18","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.ajoms.2016.04.001","volume":"28","author":"Y Enomoto","year":"2016","unstructured":"Enomoto Y, Suzuki H, Kimoto A, Asai T, Takeuchi J, Matsumoto K, et al. Concordance between clinical and histopathological diagnoses of oral lichen planus. J Oral Maxillofac Surg Med Pathol. 2016;28:381\u20134. https:\/\/doi.org\/10.1016\/j.ajoms.2016.04.001.","journal-title":"J Oral Maxillofac Surg Med Pathol."},{"key":"1711_CR19","doi-asserted-by":"publisher","first-page":"3","DOI":"10.5681\/joddd.2010.002","volume":"4","author":"M Boorghani","year":"2010","unstructured":"Boorghani M, Gholizadeh N, Taghavi Zenouz A, Vatankhah M, Mehdipour M. Oral lichen planus: clinical features, etiology, treatment and management; a review of literature. J Dent Res Dent Clin Dent Prospects. 2010;4:3\u20139. https:\/\/doi.org\/10.5681\/joddd.2010.002.","journal-title":"J Dent Res Dent Clin Dent Prospects."},{"key":"1711_CR20","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.sdentj.2012.05.002","volume":"24","author":"U Malik","year":"2012","unstructured":"Malik U, Gupta S, Malik SD, Vashishth S, Raju MS. Treatment of symptomatic oral lichen planus (OLP) with 0.1% tacrolimus powder in Oraguard-B\u2014a pilot prospective study. Saudi Dent J. 2012;24:143\u20138. https:\/\/doi.org\/10.1016\/j.sdentj.2012.05.002.","journal-title":"Saudi Dent J."},{"key":"1711_CR21","doi-asserted-by":"publisher","first-page":"e264","DOI":"10.4317\/medoral.21435","volume":"22","author":"L Pi\u00f1as","year":"2017","unstructured":"Pi\u00f1as L, Garc\u00eda-Garc\u00eda A, P\u00e9rez-Say\u00e1ns M, Su\u00e1rez-Fern\u00e1ndez R, Alkhraisat MH, Anitua E. The use of topical corticosteroides in the treatment of oral lichen planus in Spain: a national survey. Med Oral Patol Oral Cir Bucal. 2017;22:e264\u20139. https:\/\/doi.org\/10.4317\/medoral.21435.","journal-title":"Med Oral Patol Oral Cir Bucal"},{"key":"1711_CR22","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/S0140-6736(02)07683-3","volume":"359","author":"KF Schulz","year":"2002","unstructured":"Schulz KF, Grimes DA. Generation of allocation sequences in randomised trials: chance, not choice. Lancet. 2002;359:515\u20139.","journal-title":"Lancet"},{"key":"1711_CR23","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/S0140-6736(02)07750-4","volume":"359","author":"KF Schulz","year":"2002","unstructured":"Schulz KF, Grimes DA. Allocation concealment in randomised trials: defending against deciphering. Lancet. 2002;359:614\u20138. https:\/\/doi.org\/10.1016\/S0140-6736(02)07750-4.","journal-title":"Lancet"},{"key":"1711_CR24","first-page":"345","volume":"53","author":"PJ Karanicolas","year":"2010","unstructured":"Karanicolas PJ, Farrokhyar F, Bhandari M. Blinding: who, what, when, why, how? Can J Surg. 2010;53:345\u20138.","journal-title":"Can J Surg"},{"key":"1711_CR25","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.3758\/BRM.41.4.1149","volume":"41","author":"F Faul","year":"2009","unstructured":"Faul F, Erdfelder E, Buchner A, Lang AG. Statistical power analyses using G* Power 3.1: tests for correlation and regression analyses. Behav Res Methods. 2009;41:1149\u201360.","journal-title":"Behav Res Methods"},{"key":"1711_CR26","unstructured":"Hylown Consulting LLC. Power and Sample Size Calculator. In: power and sample size. 2013. http:\/\/powerandsamplesize.com\/Calculators\/Compare-2-Means\/2-Sample-Equality. Accessed 1 Sept 2018."},{"key":"1711_CR27","volume-title":"Sample size calculations in clinical research","author":"SC Chow","year":"2018","unstructured":"Chow SC, Shao J, Wang H. Sample size calculations in clinical research. 2nd ed. Boca Raton: CRC Press; 2018.","edition":"2"},{"key":"1711_CR28","first-page":"282","volume":"38","author":"G Kaur","year":"2017","unstructured":"Kaur G, Sandal A, Dhillon NS. Lycopene and human health\u2014a review. Agric Rev. 2017;38:282\u20139.","journal-title":"Agric Rev"},{"key":"1711_CR29","doi-asserted-by":"publisher","first-page":"249","DOI":"10.5005\/jp-journals-10015-1091","volume":"2","author":"R Kini","year":"2011","unstructured":"Kini R, Nagaratna DV, Saha A, Praveen BN. Therapeutic management of oral lichen planus: a review for the clinicians. World J Dent. 2011;2:249\u201353. https:\/\/doi.org\/10.5005\/jp-journals-10015-1091.","journal-title":"World J Dent."},{"key":"1711_CR30","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1111\/jop.12093","volume":"42","author":"DS Salgado","year":"2013","unstructured":"Salgado DS, Jeremias F, Capela MV, Onofre MA, Massucato EM, Orrico SR. Plaque control improves the painful symptoms of oral lichen planus gingival lesions. A short-term study. J Oral Pathol Med. 2013;42:728\u201332. https:\/\/doi.org\/10.1111\/jop.12093.","journal-title":"J Oral Pathol Med"},{"key":"1711_CR31","unstructured":"World Health Organization. WHO guidelines on drawing blood: best practices in phlebotomy. World Health Organization. 2010. https:\/\/www.euro.who.int\/__data\/assets\/pdf_file\/0005\/268790\/WHO-guidelines-on-drawing-blood-best-practices-in-phlebotomy-Eng.pdf?ua=1. Accessed 25 Aug 2018."},{"key":"1711_CR32","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/s0891-5849(99)00264-6","volume":"28","author":"LJ Roberts II","year":"2000","unstructured":"Roberts LJ II, Morrow JD. Measurement of F2-isoprostanes as an index of oxidative stress in vivo. Free Radic Biol Med. 2000;28:505\u201313. https:\/\/doi.org\/10.1016\/s0891-5849(99)00264-6.","journal-title":"Free Radic Biol Med"},{"key":"1711_CR33","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1067\/mjd.2002.120535","volume":"46","author":"F Kaliakatsou","year":"2002","unstructured":"Kaliakatsou F, Hodgson TA, Lewsey JD, Hegarty AM, Murphy AG, Porter SR. Management of recalcitrant ulcerative oral lichen planus with topical tacrolimus. J Am Acad Dermatol. 2002;46:35\u201341. https:\/\/doi.org\/10.1067\/mjd.2002.120535.","journal-title":"J Am Acad Dermatol"},{"key":"1711_CR34","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1111\/j.1365-2133.2007.08106.x","volume":"4","author":"M Escudier","year":"2007","unstructured":"Escudier M, Ahmed N, Shirlaw P, Setterfield J, Tappuni A, Black MM, et al. A scoring system for mucosal disease severity with special reference to oral lichen planus. Br J Dermatol. 2007;4:765\u201370. https:\/\/doi.org\/10.1111\/j.1365-2133.2007.08106.x.","journal-title":"Br J Dermatol"},{"key":"1711_CR35","volume-title":"Medical statistics at a glance","author":"A Petrie","year":"2009","unstructured":"Petrie A, Sabin C. Medical statistics at a glance. 2nd ed. West Sussex: Wiley; 2009.","edition":"2"},{"key":"1711_CR36","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1111\/j.1529-8019.2010.01322.x","volume":"23","author":"BJ Schlosser","year":"2010","unstructured":"Schlosser BJ. Lichen planus and lichenoid reactions of the oral mucosa. Dermatol Ther. 2010;23:251\u201367. https:\/\/doi.org\/10.1111\/j.1529-8019.2010.01322.x.","journal-title":"Dermatol Ther"},{"key":"1711_CR37","doi-asserted-by":"publisher","first-page":"639","DOI":"10.4103\/0970-9290.93448","volume":"22","author":"N Saawarn","year":"2011","unstructured":"Saawarn N, Shashikanth MC, Saawarn S, Jirge V, Chaitanya NC, Pinakapani R. Lycopene in the management of oral lichen planus: a placebo-controlled study. Indian J Dent Res. 2011;22:639\u201343. https:\/\/doi.org\/10.4103\/0970-9290.93448.","journal-title":"Indian J Dent Res"},{"key":"1711_CR38","doi-asserted-by":"publisher","first-page":"4","DOI":"10.5958\/2395-6194.2016.00002.3","volume":"2","author":"KS Shekhawat","year":"2016","unstructured":"Shekhawat KS, Deepak TA, Srivastava C. Assessment of lycopene and levamisole in management of oral lichen planus\u2014a comparative study. Oral Surg Oral Med Oral Pathol Oral Radiol. 2016;2:4\u201310.","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"1711_CR39","first-page":"658","volume":"75","author":"F Arbabi-Kalati","year":"2017","unstructured":"Arbabi-Kalati F, Farahmand MM. Evaluation of the efficacy of lycopene in the management of oral lichen planus: a pilot randomized clinical trial. Tehran Univ Med J. 2017;75:658\u201362.","journal-title":"Tehran Univ Med J"},{"key":"1711_CR40","first-page":"193","volume":"3","author":"HH Hazzaa","year":"2020","unstructured":"Hazzaa HH, Elsaadany B, Ahmed EM, Ali SAM, Abdulhady EM. Oral lycopene effect on the salivary malondialdehyde levels in symptomatic oral lichen planus patients: clinical and biochemical study. J Oral Health Dent. 2020;3:193\u2013200.","journal-title":"J Oral Health Dent"},{"key":"1711_CR41","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1034\/j.1600-0714.2003.00173.x","volume":"32","author":"M Carbone","year":"2003","unstructured":"Carbone M, Goss E, Carrozzo M, Castellano S, Conrotto D, Broccoletti R, et al. Systemic and topical corticosteroid treatment of oral lichen planus: a comparative study with long-term follow-up. J Oral Pathol Med. 2003;32:323\u20139.","journal-title":"J Oral Pathol Med"},{"key":"1711_CR42","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1034\/j.1600-0714.2003.00173.x","volume":"22","author":"M Radwan-Oczko","year":"2013","unstructured":"Radwan-Oczko M. Topical application of drugs used in treatment of oral lichen planus lesions. Adv Clin Exp Med. 2013;22:893\u20138. https:\/\/doi.org\/10.1034\/j.1600-0714.2003.00173.x.","journal-title":"Adv Clin Exp Med."},{"key":"1711_CR43","first-page":"58","volume":"6","author":"NP Selvam","year":"2013","unstructured":"Selvam NP, Dayanand AA. Lycopene in the management of oral submucous fibrosis. Asian J Pharm Clin Res. 2013;6:58\u201361.","journal-title":"Asian J Pharm Clin Res"},{"key":"1711_CR44","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/B978-0-12-381043-4.00004-0","volume":"58","author":"J Glaeser","year":"2011","unstructured":"Glaeser J, Nuss AM, Berghoff BA, Klug G. Singlet oxygen stress in microorganisms. Adv Microb Physiol. 2011;58:141\u201373.","journal-title":"Adv Microb Physiol"},{"key":"1711_CR45","doi-asserted-by":"publisher","first-page":"e19652","DOI":"10.1371\/journal.pone.0019652","volume":"6","author":"RE Simone","year":"2016","unstructured":"Simone RE, Russo M, Catalano A, Monego G, Froehlich K, Boehm V, et al. Lycopene inhibits NF-kB-mediated IL-8 expression and changes redox and PPAR\u03b3 signalling in cigarette smoke\u2013stimulated macrophages. PLoS ONE. 2016;6:e19652. https:\/\/doi.org\/10.1371\/journal.pone.0019652.","journal-title":"PLoS ONE"},{"key":"1711_CR46","doi-asserted-by":"publisher","first-page":"90","DOI":"10.4162\/nrp.2017.11.2.90","volume":"11","author":"JH Cha","year":"2017","unstructured":"Cha JH, Kim WK, Ha AW, Kim MH, Chang MJ. Anti-inflammatory effect of lycopene in SW480 human colorectal cancer cells. Nutr Res Pract. 2017;11:90\u20136. https:\/\/doi.org\/10.4162\/nrp.2017.11.2.90.","journal-title":"Nutr Res Pract"},{"key":"1711_CR47","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1111\/j.1600-0714.2010.00946.x","volume":"39","author":"MR Roopashree","year":"2010","unstructured":"Roopashree MR, Gondhalekar RV, Shashikanth MC, George J, Thippeswamy SH, Shukla A. Pathogenesis of oral lichen planus\u2014a review. J Oral Pathol Med. 2010;39:729\u201334. https:\/\/doi.org\/10.1111\/j.1600-0714.2010.00946.x.","journal-title":"J Oral Pathol Med"},{"key":"1711_CR48","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1034\/j.1600-0714.2001.301006.x","volume":"30","author":"LL Muzio","year":"2001","unstructured":"Muzio LL, Della Valle A, Mignogna MD, Mignogna MD, Pannone G, Bucci P, et al. The treatment of oral aphthous ulceration or erosive lichen planus with topical clobetasol propionate in three preparations: a clinical and pilot study on 54 patients. J Oral Pathol Med. 2001;30:611\u20137. https:\/\/doi.org\/10.1034\/j.1600-0714.2001.301006.x.","journal-title":"J Oral Pathol Med"},{"key":"1711_CR49","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.ejso.2006.09.028","volume":"33","author":"MD Mignogna","year":"2007","unstructured":"Mignogna MD, Fedele S, Lo Russo L, Mignogna C, de Rosa G, Porter SR. Field cancerization in oral lichen planus. Eur J Surg Oncol. 2007;33:383\u20139. https:\/\/doi.org\/10.1016\/j.ejso.2006.09.028.","journal-title":"Eur J Surg Oncol"},{"key":"1711_CR50","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1007\/s12105-011-0318-3","volume":"6","author":"I Kaplan","year":"2012","unstructured":"Kaplan I, Ventura-Sharabi Y, Gal G, Calderon S, Anavi Y. The dynamics of oral lichen planus: a retrospective clinicopathological study. Head Neck Pathol. 2012;6:178\u201383. https:\/\/doi.org\/10.1007\/s12105-011-0318-3.","journal-title":"Head Neck Pathol"},{"key":"1711_CR51","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s00394-003-0415-5","volume":"42","author":"F Visioli","year":"2003","unstructured":"Visioli F, Riso P, Grande S, Galli C, Porrini M. Protective activity of tomato products on in vivo markers of lipid oxidation. Eur J Nutr. 2003;42:201\u20136. https:\/\/doi.org\/10.1007\/s00394-003-0415-5.","journal-title":"Eur J Nutr"},{"key":"1711_CR52","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.freeradbiomed.2015.03.004","volume":"83","author":"TJ van\u2019T Erve","year":"2015","unstructured":"van\u2019T Erve TJ, Lih FB, Kadiiska MB, Deterding LJ, Eling TE, Mason RP. Reinterpreting the best biomarker of oxidative stress: The 8-iso-PGF(2\u03b1)\/PGF(2\u03b1) ratio distinguishes chemical from enzymatic lipid peroxidation. Free Radic Biol Med. 2015;83:245\u201351.","journal-title":"Free Radic Biol Med"},{"key":"1711_CR53","first-page":"129","volume":"60","author":"H Suleyman","year":"2009","unstructured":"Suleyman H, Dursun H, Bilici M, Cadirci E, Halici Z, Gulaboglu M, Albayrak F. Relation of adrenergic receptors, which have roles in gastroprotective and anti-inflammatory effect of adrenal gland hormones, with cyclooxygenase enzyme levels in rats. J Physiol Pharmacol. 2009;60:129\u201334.","journal-title":"J Physiol Pharmacol"},{"key":"1711_CR54","first-page":"1168.3","volume":"27","author":"HY Lin","year":"2013","unstructured":"Lin HY, Lin H, Lu DY. Lycopene inhibits cyclooxygenase-2 and inflammatory mediator expression in microglia. FASEB J. 2013;27:1168.3.","journal-title":"FASEB J"},{"key":"1711_CR55","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1136\/thx.2004.035592","volume":"60","author":"P Montuschi","year":"2005","unstructured":"Montuschi P, Macagno F, Parente P, Valente S, Lauriola L, Ciappi G, et al. Effects of cyclo-oxygenase inhibition on exhaled eicosanoids in patients with COPD. Thorax. 2005;60:827\u201333.","journal-title":"Thorax"}],"container-title":["BMC Oral Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12903-021-01711-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12903-021-01711-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12903-021-01711-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,15]],"date-time":"2021-07-15T09:07:25Z","timestamp":1626340045000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcoralhealth.biomedcentral.com\/articles\/10.1186\/s12903-021-01711-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,15]]},"references-count":55,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1711"],"URL":"https:\/\/doi.org\/10.1186\/s12903-021-01711-z","relation":{},"ISSN":["1472-6831"],"issn-type":[{"value":"1472-6831","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,15]]},"assertion":[{"value":"15 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Research Ethics committee of the Faculty of Dentistry, Alexandria University, Egypt (IRB NO: 00010556) - (IORG 0008839) approved the study in September 2018. Informed consent was obtained from all individual participants included in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Patients signed informed consent regarding publishing their data and photographs in an online open access publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"343"}}